Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized,controlled trial

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 226-232

  Curtis, Peter J ^a   Dhatariya, Ketan ^b   Sampson, Mike ^b   Kroon, Paul A ^c   Potter, John ^a   Cassidy, Aedín ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; FLAVAN 3 OL DERIVATIVE; FLAVONOID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ISOFLAVONE DERIVATIVE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; FLAVONOIDS; HUMANS; INSULIN RESISTANCE; ISOFLAVONES; LIPOPROTEINS; MIDDLE AGED; POSTMENOPAUSE;

EID: 84859080819     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1443     Document Type: Article

References (40)

1. International Diabetes Federation. IDF Diabetes Atlas, Fourth Edition. Brussels, Belgium, International Diabetes Federation, 2009
2. Stettler C, Allemann S, Jüni P, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: metaanalysis of randomized trials. Am Heart J 2006;152:27-38 (Pubitemid 43974725)
3. Sarwar N, Gao P, Seshasai SR, et al.; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-2222
4. Kautzky-Willer A, Kamyar MR, Gerhat D, et al. Sex-specific differences inmetabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. Gend Med 2010;7:571-583
5. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007;85:895-909 (Pubitemid 46393524)
6. Buijsse B, Feskens EJ, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med 2006;166:411-417
7. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: ameta-analysis of randomized controlled trials. Am J Clin Nutr 2008;88:38-50 (Pubitemid 351988681)
8. Wang-Polagruto JF, Villablanca AC, Polagruto JA, et al. Chronic consumption of flavanolrich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal-women. J Cardiovasc Pharmacol 2006;47(Suppl. 2):S177-S186; discussion S206-S209
9. Schewe T, Steffen Y, Sies H. How dodietary flavanols improve vascular function? A position paper. Arch Biochem Biophys 2008;476:102-106
10. Ueda M, Nishiumi S, Nagayasu H, Fukuda I, Yoshida K, Ashida H. Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle. Biochem Biophys Res Commun 2008;377:286-290
11. Odegaard AO, Koh WP, Butler LM, et al. Dietary patterns and incident type 2 diabetes in Chinese men and women: the Singapore Chinese Health Study. Diabetes Care 2011;34:880-885
12. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a metaanalysis of 11 randomized controlled trials. Am J Clin Nutr 2007;85:1148-1156 (Pubitemid 46557934)
13. Li SH, Liu XX, Bai YY, et al. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr 2010;91:480-486
14. Ricci E, Cipriani S, Chiaffarino F, Malvezzi M, Parazzini F. Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: a meta-analysis of randomized controlled trials. Menopause 2010;17:1080-1086
15. Balzer J, Rassaf T, Heiss C, et al. Sustained benefits invascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 2008;51:2141-2149 (Pubitemid 351713684)
16. Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr 2009;139:1700-1706
17. Jayagopal V, Albertazzi P, Kilpatrick ES, et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002;25:1709-1714 (Pubitemid 41071075)
18. Schroeter H, Heiss C, Balzer J, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006;103:1024-1029 (Pubitemid 43212215)
19. Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003;23: 1066-1071 (Pubitemid 36713562)
20. Cooper KA, Campos-Giménez E, Jiménez Alvarez D, Nagy K, Donovan JL, Williamson G. Rapid reversed phase ultra-performance liquid chromatography analysis of themajor cocoa polyphenols and inter-relationships of their concentrations in chocolate. J Agric Food Chem 2007;55:2841-2847 (Pubitemid 46668287)
21. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005;81(Suppl.):243S-255S
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419 (Pubitemid 15018832)
24. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410 (Pubitemid 32269192)
25. Setchell KD, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 2006;136:2188-2193 (Pubitemid 44156823)
26. Jia L, Liu X, Bai YY, et al. Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2010;92:218-225
27. Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117-125
28. Yasuda A, Natsume M, Osakabe N, Kawahata K, Koga J. Cacao polyphenols influence the regulation of apolipoprotein in HepG2 and Caco2 cells. J Agric Food Chem 2011;59:1470-1476
29. Duncan RE, El-Sohemy A, Archer MC. Regulation ofHMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin. Cancer Lett 2005;224:221-228 (Pubitemid 40725843)
30. Webb DR, Khunti K, Silverman R, et al. Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia 2010;53:1190-1198
31. Nakamura K, Sakurai M, Miura K, et al. Homeostasis model assessment ofinsulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men. Diabetologia 2010;53:1894-1902
32. Liu ZM, Chen YM, Ho SC. Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2011;93:1092-1101
33. Fu Z, Liu D. Long-term exposure togenistein improves insulin secretory function of pancreatic beta-cells. Eur J Pharmacol 2009;616:321-327
34. van Dieren S, Peelen LM, Nöthlings U, et al. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 2011;54:264-270
35. van der Heijden AA, Ortegon MM, Niessen LW, Nijpels G, Dekker JM. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: the Hoorn Study. Diabetes Care 2009;32:2094-2098
36. Mellor DD, Sathyapalan T, Kilpatrick ES, Beckett S, Atkin SL. High-cocoa polyphenolrich chocolate improves HDL cholesterol in type 2 diabetes patients. Diabet Med 2010;27:1318-1321
37. Howes JB, Tran D, Brillante D, Howes LG. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes Obes Metab 2003;5:325-332 (Pubitemid 37138863)
38. Desch S, Schmidt J, Kobler D, et al. Effect of cocoa products on blood pressure: systematic review andmeta-analysis. Am J Hypertens 2010;23:97-103
39. Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG, Hui RT. Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 8 February 2011 [Epub ahead of print]
40. Jenkins DJ, Kendall CW, McKeown-Eyssen G, et al. Effect of alow-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008;300:2742-2753